Fluoxetine for overweight or obese adults

<p>Obesity is a problem worldwide and several Cochrane Reviews examine interventions that might help to prevent or reduce it. These were added to in October 2019 with a new review examining the evidence on the drug fluoxetine. Here’s the lead author, Alejandro Gonzalez Garay from the National Institute of Paediatrics in Mexico City to let us know what they found.</p><img src="http://feeds.feedburner.com/~r/PodcastsFromTheCochraneLibrary/~4/zK6SiA59qH8" height="1" width="1" alt=""/>